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Induction of Inflammatory Cytokines by a Keratin
Mutation and their Repression by a Small Molecule
in a Mouse Model for EBS
Hong Lu1,4, Jian Chen1,5, Laura Planko1, Paola Zigrino2, Ludger Klein-Hitpass3 and Thomas M. Magin1
Epidermolysis bullosa simplex (EBS) is a skin disorder caused by mutations in keratin (K) 5 or K14 genes. It is
widely regarded as a mechanobullous disease, resulting from a weakened cytoskeleton, causing extensive
cytolysis. It was postulated by others that certain K14 mutations induce tumor necrosis factor-a (TNF-a) and
increase apoptosis. Here, we report that in K5/ mice and in a cell culture model of EBS, the mRNA and protein
levels of TNF-a remain unaltered. Transcriptome analysis of K5/ mice revealed, however, that the
proinflammatory cytokines IL-6 and IL-1b were significantly upregulated at the mRNA level in K5/ mouse
skin. These results were confirmed by TaqMan real-time PCR and ELISA assays. We hypothesize that keratin
mutations contribute to EBS in a mouse model by inducing local inflammation that mediates a stress response.
Following clinical reports, we applied the small molecule doxycycline to K5/ mice. We demonstrate that
doxycycline extended the survival of neonatal K5/ mice from less than 1 to up to 8 hours. Microarray and
TaqMan real-time PCR showed a downregulation of matrix metalloproteinase 13 and IL-1b, indicating an effect
of doxycycline on transcription. Our data offer a novel small molecule-based therapy approach for EBS.
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INTRODUCTION
Epidermolysis bullosa simplex (EBS) is a dominantly inherited
skin disorder caused by mutations in keratin (K) 5 or K14
genes that is characterized by cytoplasmic protein aggregates
and extensive cytolysis. It is widely regarded as a mechano-
bullous disease, resulting from an altered cytoskeleton
unable to provide support against mechanical stress. Pre-
viously, we and others have generated K5 and K14 mutant
mice serving as models for EBS (Lloyd et al., 1995; Cao et al.,
2001; Peters et al., 2001). Of these, K5/ mice develop the
most severe condition owing to the absence of keratin
filaments in the basal epidermis, followed by a complete
detachment of the epidermis from the underlying dermis.
The resulting cytolysis causes death of neonates during the
first hour after birth with full penetrance (Peters et al., 2001).
Although it is well established that EBS is mainly caused
by mechanical trauma of an epidermis that expresses mutant
keratins, additional EBS pathomechanisms have recently
emerged. Tumor necrosis factor-a (TNF-a) has been hypothe-
sized to contribute to the severe Dowling–Meara form of EBS,
caused by a point mutation at Arg 125 in K14 (Yoneda et al.,
2004). TNF-a is a proinflammatory cytokine that induces
apoptosis in some cell types (Yeh et al., 1998; Hsu and Twu,
2000). It exerts its effects by binding to TNF-a receptors TNF-
R1 and TNF-R2. The cytotoxic effects of TNF-a are mediated
by TNF-R1, which has a cytoplasmic death domain that
interacts with an adaptor protein, TNF-a receptor-associated
death domain, following ligand binding. TNF-a receptor-
associated death domain subsequently interacts with addi-
tional adapter proteins receptor-interacting protein, TNF-R-
associated factor 2, and Fas-associated death domain, which
recruits and activates pro-caspase-8. Caspase-8 then oligo-
merizes and is activated by self-cleavage, and initiates a
protease cascade that leads to apoptosis. Yoneda et al. (2004)
have suggested that TNF-a mediates cytotoxicity in a
keratinocyte model of EBS, based on HaCaT keratinocytes
transiently transfected with a K14 mutant (K14Arg125Cys).
Using this cell culture model of EBS, they reported that K14
aggregates led to the release of TNF-a and the subsequent
activation of the TNF-a receptor by an autocrine/paracrine
pathway, which resulted in cell death.
In view of these reports, we considered the hypothesis that
additional mechanisms and not only mechanical weakness
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contribute to EBS. Identification of such mechanisms would
offer potential targets for novel therapy approaches. Given
the significant problems accompanying gene therapy ap-
proaches of EBS, alternative efforts are indeed necessary
(Kirfel et al., 2002; Arin and Roop, 2004). One clinical
study has recently suggested that the systemic application
of tetracycline to patients suffering from the severe
Dowling–Meara form of EBS leads to a significant reduction
of the blistering and less fragile epidermis (Retief et al., 1999).
Tetracyclines can act as antibiotics by inhibiting bacterial
protein synthesis, but recent work has shown that they are
pluripotent drugs that affect many cellular functions: mino-
cycline reduces inflammation and protects against focal
cerebral ischemia (Yrjanheikki et al., 1999); tetracyclines
affect prion infectivity through a direct interaction with
proteinase-resistant forms of the prion protein (Forloni
et al., 2002); doxycycline modulates smooth muscle cell
growth, migration, and matrix remodeling after arterial injury
(Bendeck et al., 2002).
Here, we report on the systemic treatment of K5/ mice
serving as an animal model for EBS, by doxycycline. We
demonstrate that the systemic application of physiological
concentrations of doxycycline prolonged the life of neonatal
K5/ mice. Affymetrix analysis revealed that this was
accompanied by changes at the transcriptional level.
Proinflammatory cytokines IL-6 and IL-1b were significantly
upregulated at the mRNA and protein level in K5/ mice
skin. In contrast to other studies, however, the mRNA and
protein levels of TNF-a remained unchanged in mice and in a
cell culture model. At the same time, genes involved in tissue
remodeling were repressed. We hypothesize that mutations
in genes that cause EBS and related disorders not only lead to
cell fragility, but cause local inflammation, possibly by
mediating a stress response.
RESULTS
Absence of TNF signaling in K5/ mice and in a cell culture
model of EBS
EBS is a blistering cutaneous disease featuring protein
aggregates. Recently, TNF-a-mediated cytotoxity in a kerati-
nocyte model of EBS was reported (Yoneda et al., 2004). In
that study, HaCaT keratinocytes transiently transfected with
K14 (R125C) were found to release TNF-a with a subsequent
activation of the TNF-a receptor by an autocrine/paracrine
pathway, which resulted in cell death. A well-established EBS
mouse model, K5/ mice (Peters et al., 2001) and a HaCaT
keratinocyte line expressing mutant K14 (R125C) serving as
EBS cell models (Werner et al., 2004) were used to investigate
whether TNF-a was induced in these models. First, we
examined the potential role of TNF-a, which is expressed in
the epidermis, in K5-deficient mouse skin (Kondo and
Sauder, 1997). We quantified TNF-a protein expression by
ELISA (Figure 1g) and found no significant difference of TNF-a
expression between K5/ (20279.8 pg/mg total protein) and
wild-type (wt) control animals (192713 pg/mg total protein),
P¼0.49 (Figure 1g). Therefore, neither the extensive cytolysis
nor K14 aggregates present in K5/ epidermis stimulated
TNF-a secretion. Consistent with these data, immunofluores-
cence analysis of frozen skin sections using TNF-a antibodies
showed no difference between K5/ and wt back skin (Figure
1a and b). Second, we used mouse MGU74Av2 microarrays
(Affymetrix, Santa Clara, CA) for large-scale gene expression
profiling in mouse skin between K5/ and wt controls
(GSE760). A comprehensive analysis of genes relevant to the
TNF-a pathway failed to reveal differentially expressed genes
related to the TNF-a pathway when mRNA expression profile
from K5/ and wt mice was compared (Table 1).
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Figure 1. TNF-a expression in an EBS mouse and a cell culture model.
(a) Immunofluorescence of TNF-a in K5/ and (b) wt skin (bar¼ 10 mm);
TNF-a immunofluorescence in cultured MCF7 cell lines, (c) K14 and
(d) TNF-a staining in stably transfected mutant K14 ArgR125Cys MCF-7 cell
line, (e) K14 and (f) TNF- a staining in stably transfected wt K14wt MCF-7 cell
line. Bar¼10 mm. (g) Quantification of TNF-a protein expression in
K5/ versus wt epidermis. Amount of TNF-a protein in K5/ epidermis
(black bar, 20279.8 pg/mg total protein, n¼ 6) and wt (white bar,
192713 pg/mg total protein, n¼ 6). Student’s t-test showed no TNF-a
difference between K5/ and wt epidermis, P¼ 0.49. (h) Quantification of
TNF-a protein expression. Measurements were taken in K14 ArgR125Cys
versus wt K14wt MCF-7-transfected cell lines using ELISA (n¼ 3).
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Given that these data were in contrast to a previous study
using HaCaT keratinocytes transiently transfected with the
most frequent EBS mutant K14 Arg125Cys, we reasoned that
the failure to induce TNF signaling in K5/ mice might be
due to the presence of wt K14 (Yoneda et al., 2004).
To extend our in vivo analysis to a cell culture model,
we switched to HaCaT and to MCF-7 cells, which were
both stably transfected with the mutant K14 Arg125Cys created
previously (Werner et al., 2004). In both cell types, we found
no changes in TNF-a by immunofluorescence analysis (Figure
1c–f). Next, TNF-a levels secreted into the medium and inside
cells were measured with a solid-phase ELISA. Repeated
measurements revealed that TNF-a was not increased in the
media supernatants of K14 mutant (16.6 pg/ml) compared to
those from control transfectants (20.1 pg/ml; Figure 1h). The
expression level of TNF-a protein in mutant-transfected cells
(44 pg/ml) was lower as in mock (47.7 pg/ml)- or K14 wt-
transfected cells (57 pg/ml; Figure 1h). Collectively, our data
have demonstrated that neither the absence of K5 nor the
presence of mutant K14 or of keratin aggregates stimulate
TNF-a secretion in both EBS models. To our knowledge,
TNF-a levels have not been examined in EBS patients.
Increased IL-6 and IL-1 mRNA levels in K5/ skin
The absence of TNF signaling does not exclude a role of other
proinflammatory cytokines. Therefore, we performed a
microarray analysis from neonatal K5/ and wt skin. This
revealed that 85 genes were up- and 31 were downregulated
upon loss of K5. Of these, the mRNA for IL-6 was increased
3.46-fold in K5/ skin versus wt skin, the one encoding
chemokine (C–X–C motif) ligand 1 was upregulated 4.05-fold
(Table 2). This was confirmed by TaqMan real-time quanti-
tative reverse transcription (RT)-PCR (Figure 2a). IL-6 was
significantly upregulated in the skin of K5/ mice (8.47-fold
increase, Po0.05). The transcript of chemokine (C–X–C motif)
was little in wt, but statistics show no significant difference
comparing with K5/ skin (Figure 2b, P¼ 0.26). IL-1b was
also increased in the skin of K5/ mice (5.72-fold increase,
Po0.05; Figure 2a). Furthermore, we analyzed IL-6 and
IL-1b at the protein level in K5/ and wt epidermis. In the
former, the content of IL-1b was increased significantly
(8.8070.18 pg/mg total protein, Po0.05) compared with wt
controls (7.2570.15 pg/mg total protein). Owing to the very
low levels of IL-6, however, statistic analysis showed that
there was no significant difference of IL-6 expression between
K5/ (0.08670.036 pg/mg total protein) and wt control
mice (0.05770.028 192 13 pg/mg total protein, P¼0.52,
Figure 2c).
Extended survival of K5/ mice following small molecule
treatment
K5, together with K14 and K15, forms the keratin cytoske-
leton of basal epidermis. Previously, we reported that K5þ /
mice die in the first hour after birth (n¼ 200) with full
penetrance because the inability to form a keratin cytoske-
leton in their basal epidermis causes extensive fragility. In a
first attempt to improve this condition, pregnant K5þ /
females were systemically treated with doxycycline, starting
Table 1. Expression of genes related to the TNF-a pathway analyzed by MGU74Av2 microarray
Genes Knockout_vs wt_skin; signal fold
X87128: Mus musculus p75 TNF receptor DNA 1.231144413 NC
U21050: Tnf receptor-associated factor 3 0.870550563 NC
X92346: Tnf receptor-associated factor 4 1.071773463 NC
D84196: mouse strain NOD (TNFA) gene 1.231144413 NC
D78141: Tnf receptor-associated factor 5/cds=(322,1998) 1.319507911 NC
AF010600: Mus musculus TNF-response element-binding protein mRNA 0.933032992 NC
U37522: Mus musculus TNF-related apoptosis-inducing ligand (TRAIL) mRNA 1.319507911 NC
L35302: Tnf receptor-associated factor 1 1.071773463 NC
U90926: Mus musculus putative TNF-resistance related protein mRNA 1.319507911 NC
AJ007749: Mus musculus mRNA for caspase-8 1 NC
U54803: caspase-3, apoptosis-related cysteine protease 0.707106781 NC
Y13090: Mus musculus mRNA for caspase-12 1.414213562 NC
U67321: caspase-7 1.148698355 NC
D28492: caspase-2 1 NC
AB005663: Mus musculus mRNA for JNK1 1.071773463 NC
AB005664: Mus musculus mRNA for JNK2, complete cds 1.071773463 NC
AB029482: Mus musculus mRNA for JNK-binding protein JNKBP12 1.148698355 NC
AB005662: Mus musculus mRNA for JNK/SAPK-associated protein-1 1.319507911 NC
U18310: SAPK/Erk/kinase 1 1.148698355 NC
NC, no change; TNF-a, tumor necrosis factor-a; wt, wild-type.
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at E13.5. This was based on our previous finding that the
formation of keratin aggregates typical of EBS started at E13.5
in embryonic stage (Lu et al., 2005). Treatment with the drug
prolonged the survival time of 34 K5/ pups up to 8 hours
(Table 3).
To analyze the mechanisms responsible for the prolonged
survival at the molecular level, we used Affymetrix Gene-
chips mouse MGU74Av2 for large-scale gene expression
profiling in epidermis and in skin after treatment with
doxycycline and compared it to vehicle-treated controls
(GSE760). In K5/ epidermis, 159 genes were differentially
expressed after doxycycline treatment. Fifty-nine genes were
upregulated after doxycycline treatment and 100 genes were
suppressed. Here, we focus on genes relevant to inflamma-
tion and tissue repair (Table 4). Most importantly, in K5/
epidermis, doxycycline downregulated matrix metallopro-
teinase 13 (MMP-13, also called collagenase 3) mRNA
expression (0.4-fold decrease), and upregulated various
procollagens (procollagen type III a1, 39.95-fold increase;
procollagen type I a1, 18.38-fold increase; procollagen type
VI a3, 15.03-fold increase). Moreover, doxycycline repressed
the expression of genes encoding IL-1b (0.28-fold decrease),
IFN-activated gene 202B (0.24-fold decrease), chemokine
ligand 1 (0.21-fold decrease), serine protease 12 (0.11-fold
decrease). On the other hand, it activated the serine
proteinase inhibitor gene (6.41-fold increase).
Next, TaqMan real-time relative quantitative RT-PCR was
performed with glyceraldehyde-3-phosphate dehydrogenase
as the reference gene to validate the microarray results
(Figure 3a and b). In line with the microarray data, mRNA
expression of MMP-13 and IL-1b were significantly down-
regulated in the epidermis of doxycycline-treated K5/ mice
(0.263, 0.339, 0.295, Po0.05; Figure 3a). On the other hand,
real-time RT-PCR result did not confirm the downregulation
of IFN-activated gene 202B and the upregulation of
procollagen. The statistical data showed no significant
changes (Figure 3b) because of significant deviation between
samples. This result was consistent with previous data on the
doxycycline treatment following myocardial infarction. In
this setting, left ventricular remodeling occurred in the
post-infarction period by inhibition of collagenase activity
without changing collagen (Villarreal et al., 2003). However,
there was no significant difference when we checked the
content of IL-1b in K5/epidermis after doxycycline versus
no treatment by ELISA (data was not shown). Using Western
blotting, we found a slightly decreased amount of active
MMP-13 in the epidermis after doxycycline treatment
(Figure 4). We hypothesize that these changes represent the
initiation of ‘‘matrix remodeling’’ and contributes to a
reduced bullae formation and prolongs the life of K5/
mice. These results indicate that doxycycline can partially
Table 2. Selected upregulated genes in K5/
compared to wt skin
Genes Fold
Chemokine (C–X–C motif) ligand 2 7.62
Chemokine (C–X–C motif) ligand 1 4.79
Hypoxanthine guanine phosphoribosyl transferase 3.66
IL-6 3.46
Chemokine (C–X–C motif) ligand 1 2.81
Keratin complex 2, basic gene 6a 2.01
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Figure 2. IL-6 and IL-1b induction in K5/ mice. (a) Changes in TaqMan
real-time relative quantitative RT-PCR with glyceraldehyde-3-phosphate
dehydrogenase as reference gene. Both IL-1b and IL-6 were increased in the
skin of K5/ mice (5.72- and 8.47-fold increase, Po0.05), white: controls
(n¼6), black: K5 / (n¼ 6). (b) C–X–C motif real-time relative quantitative
RT-PCR with glyceraldehyde-3-phosphate dehydrogenase expression,
P¼ 0.26. (c) The content of IL-1b in K5/ epidermis (black bar,
447.3711 pg/mg total protein, n¼ 6) and wt (white bar, 36277.4 pg/mg total
protein n¼ 6). Po0.05. The content of IL-6 in K5/ epidermis (black bar,
69.0710.9 pg/mg total protein, n¼ 6) and wt (white bar, 20.177.6 pg/mg
total protein, n¼ 6) Po 0.05.
Table 3. Surviving time of doxycycline-treated and
-untreated K5 knockout neonatal mice
Survival time (hours) Untreated Treated
o1 40 0
3 0 3
5 0 10
7 0 13
8 0 8
Total 40 34
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rescue K5/ mice and support the previous clinical study
(Retief et al., 1999; Weiner et al., 2004).
DISCUSSION
TNF-a is not involved in blister formation in EBS
TNF-a is a multifunctional cytokine and belongs to a family of
ligands that can bind to a family of receptors. The pleiotropic
actions of TNF range from proliferative responses such as cell
growth and differentiation to inflammatory effects and the
mediation of immune responses, to destructive cellular
outcomes such as apoptotic and necrotic cell death
mechanisms (MacEwan, 2002). Although some skin disease
like psoriasis – a disease of keratinocyte proliferation and
inflammation, which follow infiltration by activated T-helper
cells and mononuclear cell and the release of TNF-a, EBS is
Table 4. Differentially expressed genes in the
microarray profiling in K5/ epidermis following
doxycycline treatment
Fold
Genes downregulated
Bcl2-like 10 0.40
MMP-13 0.37
IFN-activated gene 202B 0.37
Phosphatidylinositol-4-phosphate 5-kinase, type 1a 0.36
Regulator of G-protein signaling 7 0.34
IL-1b 0.28
IFN-activated gene 202B 0.24
Insulin receptor 0.23
Distal-less homeobox 6 0.22
Chemokine (C–C motif) ligand 1 0.21
Paired box gene 6 0.20
S100 calcium binding protein A (calgranulin A) 0.13
Protease, serine 12 neurontrypsin (motopsin) 0.11
Genes upregulated
Procollagen type III a1 39.95
Insulin-like growth factor binding protein 1 32.9
Procollagen type I a1 18.38
Procollagen type VI a3 15.03
Fibrinogen gammapolypeptide 11.79
Leptin receptor 11.31
Serine (or cysteine) proteinase inhibitor, clade F, member 1 6.41
Procollagen type I a2 5.74
Twist gene homolog 1 (Drosophila) 4.50
Procollagen type V a2 3.29
Delta-like 1 homolog (Drosophila) 2.93
Procollagen type I a1 2.60
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Figure 3. Validation of gene expression changes in K5/ after doxycycline
treatment using TaqMan real-time relative quantitative RT-PCR.
(a) MMP-13 and IL-1b were decreased in the epidermis of doxycycline-treated
K5/ mice (0.263, 0.295, Po0.05). (b) No mRNA expression changes
of IFN and procollagen. White bar, doxycycline untreated (n¼ 6); black
bar, doxycycline treated (n¼6).
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Figure 4. Analysis of MMP-13 in protein extracts of skin of K5/ mice.
(a) Equal amounts (30mg) of protein extracts, isolated from epidermis (epi)
of K5/ mice treated/untreated with doxycycline were assayed by
immunoblot analysis for the presence of latent (60 kDa) and active (48 kDa)
and MMP-13. Coomassie Blue staining (lower panel) of a gel run in parallel
was used as loading control. (b) Protein levels normalized to Coomassie Blue
staining, normalization of this representative experiment is shown.
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clearly a well-established mechanobullous disease resulting
from mutations in epidermal keratins with subsequent skin
fragility and keratinocyte cytolysis, particularly following
mild mechanical stress (Fuchs and Cleveland, 1998).
Recently, however, the secretion of TNF-a was reported from
keratinocytes transiently transfected with K14 Arg125Cys.
The subsequent stimulation of TNF-R1 and caspase-depen-
dent apoptosis in an autocrine/paracrine pathway were
suggested to play an important role in the mechanism linking
keratin aggregates to cell death (Yoneda et al., 2004). Using
the same mutant K14 ArgR125Cys stably transfected into the
same keratinocytes, we were unable to identify any changes
in TNF-a release by several, highly sensitive methods. In
support, the analysis of K5/ mice by microarray analysis
and quantitative analysis of TNF-a at the protein level have
not shown any difference compared with wt mouse samples.
Therefore, our in vitro and in vivo data strongly argue that
TNF-a is not involved in EBS. Possibly, the setting of the
previous experiment – transiently transfected cells – has
contributed to the apparent difference.
We note, that on the other hand, IL-6 and IL-1b are
significantly upregulated in K5/ skin. IL-1 is an important
mediator of inflammation and tissue damage in multiple
organs, both in experimental animal models of disease and in
human diseases. The IL-1 family consists of two agonists,
IL-1a and IL-1b, two receptors, biologically active IL-1RI
and inert IL-1RII, and a specific receptor antagonist, IL-1Ra.
Epidermal keratinocytes have been shown to produce IL-1a
and IL-1b and their receptors. IL-6 is similar to IL-1 in that it
stimulates T- and B-cell proliferation and production of
acute-phase reactants (Kishimoto, 1989), and it has been
found to stimulate keratinoncyte growth in vitro (Gallucci
et al., 2004). Both IL-1b and IL-6 mediate local inflammation.
This is consistent with local inflammation that can accom-
pany rare and severe cases of EBS (Fine and Johnson, 1988).
We posit that cytokine secretion in EBS can result from
cytolysis, a process known to involve mechanical and/or
oxidative stress in keratinocytes. Furthermore, EBS keratino-
cytes are in an activated state, as indicated by the expression
of K6 (Fuchs and Cleveland, 1998).
Doxycycline can repress inflammation and remodeling tissues
in an EBS mouse model
In the past 20 years, remarkable advances have been made in
our understanding of major subtypes of EBS. These include
the more complete characterization of the breadth, severity,
and relative frequency of cutaneous and extracutaneous
manifestations within each EBS, and elucidation of the
molecular basis of most EBS subtypes (Fuchs et al., 1994;
Fine and Eady, 1999). Although eventually some of this
knowledge may result in the successful development of
beneficial gene therapies, at present there are no treatments
available that appear to result in long-term reduction in skin
blistering or improvement of mechanical skin fragility in EBS.
This was particularly disappointing, because even those
patients with the most localized forms of EBS experience
tremendous alterations in lifestyle and quality of life.
Malkinson and co-workers described their experience with
oral tetracycline treatment of a father and son affected with
the Dowling–Meara subtype of EBS (Retief et al., 1999).
Tetracycline was initially administered to a patient to treat
acne, and significant reduction in both the number of blisters
and skin fragility were noted. A dose-dependent response was
observed, with an effective dose of 1,500 mg/day. An
identical response was observed in the affected parent. Most
importantly, a long-standing benefit was observed, with
recurrence of disease activity as the dosage of tetracycline
was reduced. This study did not address the mechanism of
tetracycline affecting skin blister formation in a keratin
disorder such as EBS.
In this study, we applied doxycycline to K5/ mice, an
animal model of EBS, to get a first insight into the mechanism
of tetracycline action in diseases including EBS. Doxycyline
was chosen due to several reasons. First, it is used widely in
tet-on or tet-off systems in mice, where the correct dose and
additional parameters have been optimized (Gossen and
Bujard, 1992; Boy et al., 2006). Second, doxycycline can be
administered orally and is rapidly and almost completely
absorbed from the gastrointestinal tract and the interference
by food with absorption of doxycycline is not significant. The
most important finding in our study is that doxycycline
extended the survival time of K5/ mice from 1 to 8 hours.
This was accompanied by changes in the transcriptional
activity of B160 genes. This change puts a cautionary note
on the widespread use of tetracycline derivatives in condi-
tional transgenesis in mice.
By microarray and Taqman realtime PCR analysis, the
mRNA-encoding MMP-13 decreased after doxycycline treat-
ment. This demonstrated that doxycycline might down-
regulate MMP-13 activity that controls matrix degradation
and thereby reduce bullae formation. This is also consistent
with observation from patients in which tetracycline sup-
pressed the formation of new bullae (Retief et al., 1999;
Weiner et al., 2004). Doxycyclines and other derivatives of
tetracycline are potent MMP inhibitors (Sapadin and
Fleischmajer, 2006). Studies with chemically modified
tetracyclines have shown that the antibiotic and anti-MMP
activities lie in different regions of the molecule; with the
antibiotic activity residing at the dimethylamino group at the
carbon-4 position of the A ring, whereas the anti-MMP
activity resides in the carbon-11 carbonyl oxygen and
carbon-12 hydroxyl groups (Ryan et al., 1996). On the basis
of this anti-MMP activity, they have been used to reduce
tissue degradation in aortic aneurysms (Petrinec et al., 1996;
Boyle et al., 1998; Curci et al., 1998, 2000; Kaito et al.,
2003), periodontal disease (Ryan et al., 1996), as well as
arthritis (Greenwald et al., 1987, 1998; Brandt, 1995;
Steinmeyer et al., 1998; Shlopov et al., 1999), and are used
to prevent tumor cell invasion, metastasis (Seftor et al., 1998),
tumor angiogenesis (Tamargo et al., 1991), arterial remodel-
ing (Bendeck et al., 2002), and ocular surface repair (Smith
and Cook, 2004).
Using transcriptional profiling, our study has revealed
that the positive effect of doxycycline on blister formation
is not only exerted by dowregulation of MMP-13, but
also by a significant downregulation of IL-1b, decreasing
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inflammation. Of note, the Dowling–Meara subtype of EBS is
characterized by the presence of inflammatory blister (Fine
and Eady, 1999). Moreover, EBS with circinate erythema,
accompanied by local inflammation has been described
(Gu et al., 2003). It will be informative to investigate inflamma-
tory cytokines in such patients. The effect of tetracycline
derivatives are in line with an inhibited induction of IL-1
b-converting enzyme to reduce inflammation and to protect
against focal cerebral ischemia (Yrjanheikki et al., 1999).
Moreover, doxycycline was reported to inhibit IL-1 in the
corneal epithelium and to be most effective in the treatment
of inflammatory ocular conditions (Solomon et al., 2000;
Smith and Cook, 2004). Although our results were not
confirmed in protein level, this might be due to the oral
application of doxycycline to pregnant K5þ / females
starting from E13.5. Possibly, the level of the drug decreases
quickly in newborn K5/ embryos that might prevent further
improvement. We did not succeed in administering drugs to
neonatal K5/ pups. In the clinical report, a long-term
improvement was observed, with recurrence of disease
activity as the doses of tetracycline was reduced (Retief
et al., 1999).
Recently, a number of reports have revealed that well-
known antibiotics play multiple roles beyond their antibac-
terial activities: tetracyclines reduce prion infectivity through
a direct interaction with the proteinase-resistant form of the
prion protein (Forloni et al., 2002), and penicillin and
ceftriaxone have potential as neurotherapeutics for treating
neurodegenerative disease by acting at the trancriptional
level (Rothstein et al., 2005). Given the large number of drugs
already approved by the FDA, a systematic screen of these
compounds for additional targets may not only unravel their
mode of action but also provide novel therapy options in
diseases difficult to treat.
MATERIALS AND METHODS
Animal treatment
K5þ / and K5/ mice (BALB/c) were originally generated in our lab
(Peters et al. 2001). All mice were kept under the rule of the animal
license 50.203.2-BN 24, 20/04. Experiments were approved by the
Regierungspraesidium Koeln (Germany). To get doxycycline-treated
or -untreated neonatal pups, doxycycline (50 mg/ml doxycycline with
5% sucrose) was administered by oral route to pregnant K5þ /
females (mated to K5þ / males) starting from E13.5. Five percent
sucrose solution was administered to the control group.
Total RNA isolation
Skin was removed from neonatal mice and immediately frozen in
liquid nitrogen. RNA was extracted with TRIzol reagent (Life
Technologies-BRL, Karlsruhe, Germany) according to the protocol
of the supplier. Briefly, 50–100 mg of tissue samples were homo-
genized in 1 ml TRIzol reagent with a power homogenizer and then
extracted with 0.2 ml chloroform. The aqueous phase was pre-
cipitated by 0.5 ml isopropyl alcohol. The RNA pellets were washed
with 75% ethanol and dissolved in RNase-free water. RNA
concentration was determined by UV spectrophotometer, and then
RNA quality was checked on a 0.8% agarose gel. Total RNA samples
were stored at 801C.
Microarray analysis
Mouse MGU74Av2 microarrays (Affymetrix, Santa Clara, CA) were
used for large-scale gene expression profiling in epidermis or skin
after doxycycline treatment versus controls. The following six groups
of tissues were used in the study. Three groups were K5/ epidermis,
K5/ skin, and wt skin treated with doxycycline, another three groups
were control. Six animals were included in each group. All the total
RNA samples were isolated from tissues taken immediately after birth,
and were pooled for later microarray experiments. Array hybridization
was carried out at the core facility of the University of Mu¨nster.
Scanned images were analyzed to identify the differentially expressed
genes with MA5.0 software (Affymetrix).
Real-time RT-PCR
Quantification of five selected transcripts was performed by relative
quantitative real-time RT-PCR (ABI PRISM 7700 SDS; PE Biosystems,
Foster City, CA) (Table 5) (Chen et al., 2001). We carried out relative
quantification of starting mRNA copy numbers according to the
threshold cycle (Ct) method (Fink et al., 1998). Glyceraldehyde-
3-phosphate dehydrogenase was used as the endogenous reference
gene as it does not exhibit significant expression changes between EBS
and control mice, or doxycycline-treated and -untreated mice. The
reaction was performed in a MicroAmp Optical 96-Well Reaction
Plate. Eurogentec Reverse Transcriptase qPCR Master Mix (cat. no. RT-
QPRT-032X, Eurogentec, Scraing, Belgium) was used for a one-tube-
one-step RT-PCR in a total reaction volume of 12.5ml. Relative
quantification started from each reaction containing 10 ng of total RNA.
Reaction conditions were optimized for primers, probes, and MgCl2
concentration as outlined. Cycling conditions were 481C for 30 minutes
for RT step, followed by 951C for 10 minutes, and a two-step PCR with
60 cycles of 951C for 15 seconds and 591C for 1 minute.
Cell culture
Four cell lines were used throughout this study: human HaCaT
keratinocytes stably transfected with wt K14 or with K14(Arg125Cys),
human MCF7-wt K14-, and MCF7-K14Arg125Cys-transfected (Wer-
ner et al., 2004). Cells were grown on polystyrene flasks or dishes at
371C in a 95% O2/5% CO2 atmosphere. Cells were maintained in
DMEM with 10% fetal calf serum, penicillin/streptomycin (2 mM),
and L-glutamine (100 U/ml).
ELISA
The content of TNF-a, IL-6, and IL-1b in mouse skin or epidermis, as
well as TNF-a in cell culture medium and lysate were measured with
a solid-phase ELISA kits (Biosource, Camarillo, CA), according to the
manufacturer’s instruction. Briefly, mice were killed immediately
after birth. Skin and epidermis of K5/ mice was obtained by using
tweezers. For preparation of wt epidermis and whole-cell homo-
genates, we used the method described by Arnott et al. (2004).
The total protein concentration was determined using the BCA
protein assay. Identical amounts of total proteins were applied for
ELISA detection. The absorbance of each well was measured at
450 nm with a BioRad spectrophotometer.
Immunofluorescence analysis
Preparation of tissue samples and immunofluorescence analysis
were carried out as before (Peters et al., 2001). The following
primary antibodies were used: AF 138 against K5 (1:600, Hiss
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Diagnostics, Freiburg, Germany), a-CK14.2 against K14 (1:700,
kindly provided by L. Langbein, German Cancer Research Center,
Heidelberg, Germany), M18 against TNF-a (1:10, Santa Cruz
Biotechnology, Santa Cruz, CA), Image analysis and processing
were performed using the AxionVision 4.3 (Carl Zeiss, Goettingen,
Germany) and Adobe Photoshop 6.0 software. Secondary antibodies
used for immunofluorescence studies in recommended dilutions
were Alexa 488A- or Alexa 594-conjugated IgG (Molecular Probes,
Leiden, The Netherlands). Immunofluorescence analysis of cells was
described by our lab (Werner et al., 2004).
Immunoblot analysis
For preparation of mouse skin extracts, frozen mouse tissue was
minced and extracted in 2% SDS/phosphate-buffered saline solution,
sonicated, and incubated overnight at 41C. The homogenate was
cleared by centrifugation at 14,000 r.p.m. at 41C for 15 minutes and
processed for immunoblot analysis. Protein concentration was
assessed using the BCAs Protein assay according to the manufac-
turer’s instructions (Pierce, Rockford, IL). Proteins were separated on
SDS-polyacrylamide gels (10% acrylamide) with 10 mg of the
samples. Gels were run in duplicate, one gel was stained with
Coomassie Blue (Serva, Heidelberg, Germany), the other was
transferred to nitrocellulose membranes and transfer efficiency
controlled by Ponceau Red staining (Sigma-Aldrich, St Louis, MO).
Membranes were blocked with 5% milk in TBST for 1 hour at room
temperature. The MMP-13 antibody K73/6, kindly provided by Dr R
M Hembry (School of Biological Sciences, University of East Anglia,
Norwich, UK), was used at a dilution of 1:500 in TBST. After several
washings with TBST, bound primary antibody was revealed using a
peroxidase-conjugated secondary antibody and specific immuno-
complexes were detected using an ECL western blotting detection kit
(Amersham, Freiburg, Germany). Quantification of signal intensities
was performed using ImageQuant software supplied to ‘‘Personal
Densitometer’’ from Molecular Dynamics (Krefeld, Germany). Signal
intensities of specific bands were normalized to the intensity of the
total proteins detected by Coomassie Blue staining.
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